Emanuil Gheorghita

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

J. Cortes, R. Mesa, A. Vannucchi, 2015, JAMA oncology.

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia.

P. S. Andersen, W. Jędrzejczak, T. P. Frandsen, 2012, Blood.

antibodies, in the treatment of primary immune thrombocytopenia Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD

P. S. Andersen, T. P. Frandsen, J. Windyga, 2012 .

Results Of a Randomized, Double-Blind, Placebo-Controlled Phase III Study (JAKARTA) Of The JAK2-Selective Inhibitor Fedratinib (SAR302503) In Patients With Myelofibrosis (MF)

J. Cortes, R. Mesa, A. Vannucchi, 2013 .

Abstract 3847: The anti-hepcidin Spiegelmer® Lexaptepid Pegol (NOX-H94) as treatment of anemia of chronic disease in patients with multiple myeloma, low grade lymphoma, and CLL: A phase II pilot study

H. Ludwig, A. Cucuianu, Emanuil Gheorghita, 2014 .